ClinicalTrials.Veeva

Menu

Characteristics of NAFLD Among Type 2 Diabetes Patients

E

East Limburg Hospital

Status

Active, not recruiting

Conditions

Type2 Diabetes
Non-Alcoholic Fatty Liver Disease

Treatments

Other: Screening and studying characteristics

Study type

Interventional

Funder types

Other

Identifiers

NCT04999124
NaDiA-01

Details and patient eligibility

About

Type 2 diabetes patients have a high risk of developing NAFLD. This was confirmed during previous research, a high prevalence of NAFLD among type 2 diabetes mellitus patients was found. The investigators want to determine the characteristics of this population.

Enrollment

3,000 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18-80 years,
  • having type 2 diabetes,
  • able to understand Dutch,
  • able to understand the informed consent

Exclusion criteria

  • excessive alcohol abuse,
  • other liver disease,
  • secondary causes of steatosis

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

3,000 participants in 1 patient group

Type 2 Diabetes Mellitus patients
Other group
Treatment:
Other: Screening and studying characteristics

Trial contacts and locations

1

Loading...

Central trial contact

Leen Heyens, drs.; Geert Robaeys, prof. dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems